Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$0.36 - $0.57 $252 - $398
-700 Reduced 33.33%
1,400 $0
Q4 2021

Jan 18, 2022

SELL
$0.46 - $0.94 $92 - $188
-200 Reduced 8.7%
2,100 $0
Q3 2021

Oct 26, 2021

SELL
$0.86 - $1.21 $5,418 - $7,623
-6,300 Reduced 73.26%
2,300 $0
Q2 2021

Jul 19, 2021

SELL
$1.04 - $1.69 $6,968 - $11,323
-6,700 Reduced 43.79%
8,600 $1,000
Q1 2021

Apr 26, 2021

BUY
$1.32 - $3.79 $19,404 - $55,713
14,700 Added 2450.0%
15,300 $3,000
Q4 2020

Jan 21, 2021

SELL
$1.06 - $1.51 $1,378 - $1,963
-1,300 Reduced 68.42%
600 $0
Q2 2018

Aug 10, 2018

BUY
$5.97 - $9.58 $10,149 - $16,286
1,700 Added 850.0%
1,900 $1,000
Q1 2018

May 11, 2018

BUY
$4.21 - $7.0 $842 - $1,400
200 New
200 $0

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $15.9M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.